MedTG

MedTG is a medical technology company developing the HemoIV™ Blood Specimen Collection System, a sterile, single-use medical device designed to improve the way blood samples are collected in healthcare settings. The company’s mission is to reduce patient discomfort, improve specimen quality, and enhance safety for healthcare professionals by enabling clinical-quality blood draws directly from existing peripheral IV catheters without the need for additional needle sticks.

The HemoIV system addresses significant challenges in healthcare, including repeated venipunctures, needlestick injuries among clinical staff, and blood sample rejection caused by hemolysis and contamination. The company has completed extensive preclinical and clinical development activities, including human studies, FDA-required testing, and patent protection across the United States and international markets, while pursuing regulatory clearance for commercialization. Guided by a commitment to meaningful healthcare innovation, MedTG seeks to improve patient care, increase operational efficiency for providers, and deliver solutions that serve both medical professionals and the individuals they treat.